Europese Unie -
Deens -
EMA (European Medicines Agency)
brukinsa
beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastiske midler - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).
Europese Unie -
Deens -
EMA (European Medicines Agency)
tevimbra
novartis europharm limited - tislelizumab - esophageal squamous cell carcinoma - antineoplastiske midler - oesophageal squamous cell carcinoma (oscc) tevimbra as monotherapy is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemotherapy.
Europese Unie -
Deens -
EMA (European Medicines Agency)
vepacel
ology bioservices ireland ltd - influenzavirus (hel virion, inaktiveret), der indeholder antigen af: a / vietnam / 1203/2004 (h5n1) - influenza, human; immunization; disease outbreaks - influenzavacciner - aktiv immunisering mod h5n1-subtype af influenza a-virus. denne angivelse er baseret på immunogenicitet data fra forsøgspersoner i alderen fra 6 måneder og frem efter administration af to doser af vaccinen tilberedes med h5n1 subtype stammer. vepacel bør anvendes i overensstemmelse med officielle retningslinjer.
Denemarken -
Deens -
Lægemiddelstyrelsen (Danish Medicines Agency)
artelac 3,2 mg/ml øjendråber, opløsning, enkeltdosisbeholder
bausch & lomb ireland limited - hypromellose - øjendråber, opløsning, enkeltdosisbeholder - 3,2 mg/ml
Europese Unie -
Deens -
EMA (European Medicines Agency)
urorec
recordati ireland ltd - silodosin - prostatisk hyperplasi - urologicals - behandling af tegn og symptomer på godartet prostatisk hyperplasi (bph).
Europese Unie -
Deens -
EMA (European Medicines Agency)
silodyx
recordati ireland ltd - silodosin - prostatisk hyperplasi - urologicals - behandling af tegn og symptomer på godartet prostatisk hyperplasi (bph).
Europese Unie -
Deens -
EMA (European Medicines Agency)
silodosin recordati
recordati ireland ltd - silodosin - prostatisk hyperplasi - urologicals, alfa-antagonister adrenoreceptor - behandling af tegn og symptomer på benign prostatahyperplasi (bph) hos voksne mænd.
Denemarken -
Deens -
Lægemiddelstyrelsen (Danish Medicines Agency)
hypotron 2,5 mg tabletter
brancaster pharma ireland ltd. - midodrinhydrochlorid - tabletter - 2,5 mg
Denemarken -
Deens -
Lægemiddelstyrelsen (Danish Medicines Agency)
taptiqom 15 mikg/ml+5 mg/ml øjendråber, opløsning, enkeltdosisbeholder
paranova danmark a/s - tafluprost, timololmaleat - øjendråber, opløsning, enkeltdosisbeholder - 15 mikg/ml+5 mg/ml
Denemarken -
Deens -
Lægemiddelstyrelsen (Danish Medicines Agency)
taptiqom 15 mikg/ml+5 mg/ml øjendråber, opløsning, enkeltdosisbeholder
santen oy - tafluprost, timololmaleat - øjendråber, opløsning, enkeltdosisbeholder - 15 mikg/ml+5 mg/ml